Media coverage about PerkinElmer (NYSE:PKI) has trended somewhat positive on Monday, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. PerkinElmer earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave news articles about the medical research company an impact score of 47.5310831760224 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media stories that may have effected Accern’s scoring:
Shares of PerkinElmer (NYSE:PKI) traded up $0.34 during trading on Monday, reaching $81.20. The company had a trading volume of 548,088 shares, compared to its average volume of 555,557. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.09 and a current ratio of 2.59. The company has a market capitalization of $8,940.00, a price-to-earnings ratio of 36.74, a P/E/G ratio of 1.92 and a beta of 0.77. PerkinElmer has a 1 year low of $50.59 and a 1 year high of $81.30.
PerkinElmer (NYSE:PKI) last posted its earnings results on Thursday, November 2nd. The medical research company reported $0.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.01. The company had revenue of $554.28 million during the quarter, compared to analyst estimates of $552.38 million. PerkinElmer had a return on equity of 13.11% and a net margin of 18.27%. equities analysts anticipate that PerkinElmer will post 2.88 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Friday, January 19th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Thursday, January 18th. PerkinElmer’s dividend payout ratio (DPR) is presently 12.67%.
PKI has been the subject of several research analyst reports. Zacks Investment Research raised PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price objective for the company in a report on Monday, January 8th. Evercore ISI initiated coverage on PerkinElmer in a report on Wednesday, January 3rd. They issued an “in-line” rating and a $77.00 price objective for the company. Bank of America raised PerkinElmer from an “underperform” rating to a “neutral” rating and set a $78.00 price objective for the company in a report on Tuesday, December 19th. ValuEngine lowered PerkinElmer from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, Morgan Stanley boosted their price objective on PerkinElmer from $77.00 to $78.00 and gave the company an “overweight” rating in a report on Friday, November 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $73.62.
In other news, Director Alexis P. Michas sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $73.18, for a total transaction of $365,900.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nicholas A. Lopardo sold 24,050 shares of the company’s stock in a transaction that occurred on Tuesday, November 7th. The shares were sold at an average price of $70.72, for a total value of $1,700,816.00. The disclosure for this sale can be found here. Insiders have sold 86,336 shares of company stock valued at $6,114,917 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “PerkinElmer (PKI) Earning Somewhat Favorable Media Coverage, Accern Reports” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/01/22/perkinelmer-pki-earning-somewhat-favorable-media-coverage-accern-reports.html.
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.